产品召回

港股IPO招股书披露先例 · 1 家公司，1 项

产品召回指因产品缺陷、标签错误或不符合注册规格而实施的强制性或自愿性召回。招股书通常在风险因素、业务及概要等章节披露，内容一般涵盖召回的自愿性质、涉及批次与数量、成因（如标签印刷疏忽、注册证编号误用），并说明相关事项仅涉标签、不影响产品质量与安全，公司已通知客户并提供更新标签、无需实物退货，且未收到投诉、索赔或监管处罚，相关问题已予纠正。

合规类事项自 2026 年 8 月 24 日起递交的文件开始收录。

2026-08-28Prospectus不合规事项

深圳麦科田生物医疗技术股份有限公司Medcaptain Medical Technology Co., Ltd.02041.HK

两批次产品标签问题自愿召回

During the Track Record Period, we voluntarily implemented two Class III recalls, including two batches of coagulation test kits and one batch of infusion equipment. Both recalls were initiated to update or revise the product labeling information.
Risk Factors · 第 42 页

we identified a discrepancy between the expiration dates printed on the vial labels and those on the outer packaging due to an inadvertent printing error
Business · 第 191 页

we inadvertently labeled the outer packaging with the newly approved registration certificate numbers during the transitional period following the renewal of the relevant registrations
Business · 第 191 页

公司的解释、律师意见及原文页码定位：在 Matters 中查看

在 Matters 中按行业、时间筛选全部同类事项 →